| [February 09, 2016] |
 |
Neuropathic Pain Pipeline Review, H2 2015 - Therapeutics Developments from 100+ Companies - Research and Markets
Research and Markets (http://www.researchandmarkets.com/research/dgwj2d/neuropathic_pain)
has announced the addition of the "Neuropathic
Pain - Pipeline Review, H2 2015" report to their offering.
This report provides comprehensive information on the therapeutic
development for Multiple Myeloma (Kahler Disease), complete with
comparative analysis at various stages, therapeutics assessment by drug
target, mechanism of action (MoA), route of administration (RoA) and
molecule type, along with latest updates, and featured news and press
releases. It also reviews key players involved in the therapeutic
development for Neuropathic Pain and special features on late-stage and
discontinued projects.
The report enhances decision making capabilities and help to create
effective counter strategies to gain competitive advantage. It
strengthens R&D pipelines by identifying new targets and MOAs to produce
first-in-class and best-in-class products.
Key Topics Covered:
-
Introduction
-
Neuropathic Pain Overview
-
Therapeutics Development
-
Pipeline Products for Neuropathic Pain- Overview
-
Pipeline Products for Neuropathic Pain- Comparative Analysis
-
Neuropathic Pain- Therapeutics under Development by Companies
-
Neuropathic Pain- Therapeutics under Investigation by
Universities/Institutes
-
Neuropathic Pain- Pipeline Products Glance
-
Late Stage Products
-
Clinical Stage Products
-
Early Stage Products
-
Neuropathic Pain- Products under Development by Companies
-
Neuropathic Pain- Products under Investigation by
Universities/Institutes
-
Neuropathic Pain- Companies Involved in Therapeutics Development
Companies Mentioned
-
2-BBB Medicines BV
-
AbbVie Inc.
-
Advinus Therapeutics Ltd.
-
Adynxx, Inc.
-
Aestus Therapeutics, Inc.
-
Affectis Pharmaceuticals AG
-
Allergan Plc
-
Amura Holdings Limited
-
AnaBios Corporation
-
Anavex Life Sciences Corp.
-
AngioChem Inc.
-
Asahi Kasei Pharma Corp.
-
Astellas Pharma Inc.
-
AstraZeneca Plc
-
BCN (News - Alert) Peptides, S.A.
-
Benitec Biopharma Limited
-
BioDelivery Sciences International, Inc.
-
BioLineRx, Ltd.
-
Biomar Microbial Technologies
-
Bionomics Limited
-
Biscayne Pharmaceuticals, Inc.
-
Boehringer Ingelheim GmbH
-
Bristol-Myers Squibb Company
-
Can-Fite BioPharma Ltd.
-
Cara Therapeutics, Inc.
-
Catalyst Biosciences, Inc.
-
Cavion LLC
-
Cerecor Inc.
-
Circuit Therapeutics, Inc.
-
CLL Pharma
-
Colby Pharmaceutical Company
-
Convergence (News - Alert) Pharmaceuticals Ltd.
-
Creabilis SA
-
Crinetics Pharmaceuticals, Inc.
-
Cytogel Pharma, LLC
For more information visit http://www.researchandmarkets.com/research/dgwj2d/neuropathic_pain
View source version on businesswire.com: http://www.businesswire.com/news/home/20160209006128/en/
[ Back To TMCnet.com's Homepage ]
|
